Copyright Reports & Markets. All rights reserved.

Global Helminthic Infestations Therapeutics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Helminthic Infestations Therapeutics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by Product
      • 1.4.2 Benzimidazole
      • 1.4.3 Pyrantel
      • 1.4.4 Piperazine Citrate
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Helminthic Infestations Therapeutics Market Size Growth Rate by End User
      • 1.5.2 Enterobius vermicularis
      • 1.5.3 Taenia saginata
      • 1.5.4 Ascaris lumbricoides
      • 1.5.5 Trichuris trichiura
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Helminthic Infestations Therapeutics Market Size
      • 2.1.1 Global Helminthic Infestations Therapeutics Revenue 2014-2025
      • 2.1.2 Global Helminthic Infestations Therapeutics Sales 2014-2025
    • 2.2 Helminthic Infestations Therapeutics Growth Rate by Regions
      • 2.2.1 Global Helminthic Infestations Therapeutics Sales by Regions
      • 2.2.2 Global Helminthic Infestations Therapeutics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Helminthic Infestations Therapeutics Sales by Manufacturers
      • 3.1.1 Helminthic Infestations Therapeutics Sales by Manufacturers
      • 3.1.2 Helminthic Infestations Therapeutics Sales Market Share by Manufacturers
      • 3.1.3 Global Helminthic Infestations Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Helminthic Infestations Therapeutics Revenue by Manufacturers
      • 3.2.1 Helminthic Infestations Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Helminthic Infestations Therapeutics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Helminthic Infestations Therapeutics Price by Manufacturers
    • 3.4 Helminthic Infestations Therapeutics Manufacturing Base Distribution, Product Types
      • 3.4.1 Helminthic Infestations Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Helminthic Infestations Therapeutics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Helminthic Infestations Therapeutics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Helminthic Infestations Therapeutics Sales by Product
    • 4.2 Global Helminthic Infestations Therapeutics Revenue by Product
    • 4.3 Helminthic Infestations Therapeutics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Helminthic Infestations Therapeutics Breakdown Data by End User

    6 North America

    • 6.1 North America Helminthic Infestations Therapeutics by Countries
      • 6.1.1 North America Helminthic Infestations Therapeutics Sales by Countries
      • 6.1.2 North America Helminthic Infestations Therapeutics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Helminthic Infestations Therapeutics by Product
    • 6.3 North America Helminthic Infestations Therapeutics by End User

    7 Europe

    • 7.1 Europe Helminthic Infestations Therapeutics by Countries
      • 7.1.1 Europe Helminthic Infestations Therapeutics Sales by Countries
      • 7.1.2 Europe Helminthic Infestations Therapeutics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Helminthic Infestations Therapeutics by Product
    • 7.3 Europe Helminthic Infestations Therapeutics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Helminthic Infestations Therapeutics by Countries
      • 8.1.1 Asia Pacific Helminthic Infestations Therapeutics Sales by Countries
      • 8.1.2 Asia Pacific Helminthic Infestations Therapeutics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Helminthic Infestations Therapeutics by Product
    • 8.3 Asia Pacific Helminthic Infestations Therapeutics by End User

    9 Central & South America

    • 9.1 Central & South America Helminthic Infestations Therapeutics by Countries
      • 9.1.1 Central & South America Helminthic Infestations Therapeutics Sales by Countries
      • 9.1.2 Central & South America Helminthic Infestations Therapeutics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Helminthic Infestations Therapeutics by Product
    • 9.3 Central & South America Helminthic Infestations Therapeutics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Helminthic Infestations Therapeutics by Countries
      • 10.1.1 Middle East and Africa Helminthic Infestations Therapeutics Sales by Countries
      • 10.1.2 Middle East and Africa Helminthic Infestations Therapeutics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Helminthic Infestations Therapeutics by Product
    • 10.3 Middle East and Africa Helminthic Infestations Therapeutics by End User

    11 Company Profiles

    • 11.1 Neural Analytics, Inc.
      • 11.1.1 Neural Analytics, Inc. Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Neural Analytics, Inc. Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Neural Analytics, Inc. Helminthic Infestations Therapeutics Products Offered
      • 11.1.5 Neural Analytics, Inc. Recent Development
    • 11.2 M3 Biotechnology, Inc.
      • 11.2.1 M3 Biotechnology, Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 M3 Biotechnology, Inc. Helminthic Infestations Therapeutics Products Offered
      • 11.2.5 M3 Biotechnology, Inc. Recent Development
    • 11.3 Cerevance
      • 11.3.1 Cerevance Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Cerevance Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Cerevance Helminthic Infestations Therapeutics Products Offered
      • 11.3.5 Cerevance Recent Development
    • 11.4 Mitochon Pharmaceuticals, Inc.
      • 11.4.1 Mitochon Pharmaceuticals, Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Mitochon Pharmaceuticals, Inc. Helminthic Infestations Therapeutics Products Offered
      • 11.4.5 Mitochon Pharmaceuticals, Inc. Recent Development
    • 11.5 Peptilogics
      • 11.5.1 Peptilogics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Peptilogics Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Peptilogics Helminthic Infestations Therapeutics Products Offered
      • 11.5.5 Peptilogics Recent Development
    • 11.6 Farmoquimica S/A
      • 11.6.1 Farmoquimica S/A Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Farmoquimica S/A Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Farmoquimica S/A Helminthic Infestations Therapeutics Products Offered
      • 11.6.5 Farmoquimica S/A Recent Development
    • 11.7 biOasis Technologies, Inc.
      • 11.7.1 biOasis Technologies, Inc. Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 biOasis Technologies, Inc. Helminthic Infestations Therapeutics Products Offered
      • 11.7.5 biOasis Technologies, Inc. Recent Development
    • 11.8 HCA Healthcare, Inc.
      • 11.8.1 HCA Healthcare, Inc. Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 HCA Healthcare, Inc. Helminthic Infestations Therapeutics Products Offered
      • 11.8.5 HCA Healthcare, Inc. Recent Development
    • 11.9 Alzeca Biosciences, Inc.
      • 11.9.1 Alzeca Biosciences, Inc. Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Alzeca Biosciences, Inc. Helminthic Infestations Therapeutics Products Offered
      • 11.9.5 Alzeca Biosciences, Inc. Recent Development
    • 11.10 Johnson & Johnson
      • 11.10.1 Johnson & Johnson Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Johnson & Johnson Helminthic Infestations Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Johnson & Johnson Helminthic Infestations Therapeutics Products Offered
      • 11.10.5 Johnson & Johnson Recent Development

    12 Future Forecast

    • 12.1 Helminthic Infestations Therapeutics Market Forecast by Regions
      • 12.1.1 Global Helminthic Infestations Therapeutics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Helminthic Infestations Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.2 Helminthic Infestations Therapeutics Market Forecast by Product
      • 12.2.1 Global Helminthic Infestations Therapeutics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Helminthic Infestations Therapeutics Revenue Forecast by Product 2019-2025
    • 12.3 Helminthic Infestations Therapeutics Market Forecast by End User
    • 12.4 North America Helminthic Infestations Therapeutics Forecast
    • 12.5 Europe Helminthic Infestations Therapeutics Forecast
    • 12.6 Asia Pacific Helminthic Infestations Therapeutics Forecast
    • 12.7 Central & South America Helminthic Infestations Therapeutics Forecast
    • 12.8 Middle East and Africa Helminthic Infestations Therapeutics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Helminthic Infestations Therapeutics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Helminthic Infestations Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Helminthic Infestations Therapeutics market based on company, product type, end user and key regions.

      This report studies the global market size of Helminthic Infestations Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Helminthic Infestations Therapeutics in these regions.
      This research report categorizes the global Helminthic Infestations Therapeutics market by top players/brands, region, type and end user. This report also studies the global Helminthic Infestations Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Neural Analytics, Inc.
      M3 Biotechnology, Inc.
      Cerevance
      Mitochon Pharmaceuticals, Inc.
      Peptilogics
      Farmoquimica S/A
      biOasis Technologies, Inc.
      HCA Healthcare, Inc.
      Alzeca Biosciences, Inc.
      Johnson & Johnson

      Market size by Product
      Benzimidazole
      Pyrantel
      Piperazine Citrate
      Others
      Market size by End User
      Enterobius vermicularis
      Taenia saginata
      Ascaris lumbricoides
      Trichuris trichiura
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Helminthic Infestations Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Helminthic Infestations Therapeutics market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Helminthic Infestations Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Helminthic Infestations Therapeutics submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Helminthic Infestations Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Helminthic Infestations Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now